Hayfin Investments

Hayfin has invested in 12 companies and its latest investment was MolecuLight on Jan 05, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

MolecuLight is a Canada-based medical device company that develops and manufactures handheld point-of-care fluorescence imaging systems to analyze wound care for clinicians.
$27.5M
Jan 05, 2025
-
HeartFlow is a California-based medical technology company that provides non-invasive personalized cardiac testing and analysis for diagnosing cardiovascular diseases.
$215.9M
Mar 01, 2023
-
Monolith is a New York-based company that acquires and invests in consumer product brands and E-commerce businesses.
$230M
Sep 26, 2022
-
Keo is a Florida-based fintech platform that offers solutions such as BNPL, inventory and supply chain financing for businesses.
$20M
Jun 13, 2022
-
ADMA Biologics is a New Jersey-based biopharmaceutical company that researches and develops plasma-derived products for the treatment of infectious diseases.
$150M
Mar 25, 2022
-

Frequently Asked Questions about Hayfin

  1. What is Hayfin investing in?

    Hayfin has invested in 12 companies including MolecuLight, HeartFlow and Monolith
  2. What company did Hayfin invest in?

    Hayfin invested in a total 12 companies including MolecuLight, HeartFlow and Monolith
  1. What are the top 5 investments by Hayfin?

    The top companies in which Hayfin invested are MolecuLight, HeartFlow, Monolith, Keo and ADMA Biologics